|4Oct 25, 7:06 AM ET

ACORDA THERAPEUTICS INC 4

4 · ACORDA THERAPEUTICS INC · Filed Oct 25, 2016

Insider Transaction Report

Form 4
Period: 2016-10-21
Batycky Richard P.
Chief Tech. Off. & Site Head
Transactions
  • Sale

    Common Stock

    2016-10-21$20.30/sh2,063$41,87745,916 total
Footnotes (2)
  • [F1]Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.10 to $20.50 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION